ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase

Summary

The incidence of immune thrombocytopenia increases with older age. This population is at risk for arterial thrombosis. Due to an increased turn-over of platelets, low-dose aspirin once daily may be insufficient in this population to protect against arterial thrombosis. This study is aimed at assessing the pharmacodynamics of aspirin once daily on platelet function in these patients.

Timeline

Start

2023-01-16

Primary completion

2024-01-02

Completion

2024-01-02

Drugs

Indications